Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH) - Normandie Université Accéder directement au contenu
Article Dans Une Revue Current Research in Translational Medicine Année : 2023

Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH)

Fichier non déposé

Dates et versions

hal-04452986 , version 1 (12-02-2024)

Identifiants

Citer

Matthieu Decamp, Emilie Klein, Catherine Godon, Valentin Lestringant, Pauline Roynard, et al.. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH). Current Research in Translational Medicine, 2023, 71 (4), pp.103424. ⟨10.1016/j.retram.2023.103424⟩. ⟨hal-04452986⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More